Akari Therapeutics Ownership | Who Owns Akari Therapeutics?

Akari Therapeutics Ownership Summary

Akari Therapeutics is owned by 100.89% institutional investors, 34.23% insiders. Cerity partners is the largest institutional shareholder, holding 150.25% of AKTX shares. LUX IM Global Medtech HX is the top mutual fund, with 0.03% of its assets in Akari Therapeutics shares.

AKTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Akari Therapeutics	100.89%	34.23%	-35.12%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Cerity partners	23.64K	150.25%	$23.88K
Sabby management	179.78K	32.93%	$210.33K
Palo alto investors lp	146.02K	26.75%	$170.83K
Omnia family wealth	62.69K	11.48%	$73.34K
Cresset asset management	18.41K	3.37%	$21.54K
Accent capital management	10.00K	1.83%	$11.70K
Newedge advisors	6.80K	1.25%	$7.96K
Eversource wealth advisors	4.38K	0.80%	$5.12K
Truvestments capital	50.00	0.01%	$59.00
Cornerstone planning group	5.00	0.00%	$5.00

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sabby management	179.78K	0.38%	$210.33K
Palo alto investors lp	146.02K	0.04%	$170.83K
Omnia family wealth	62.69K	0.03%	$73.34K
Accent capital management	10.00K	0.01%	$11.70K
Eversource wealth advisors	4.38K	0.00%	$5.12K
Cresset asset management	18.41K	0.00%	$21.54K
Newedge advisors	6.80K	-	$7.96K
Cornerstone planning group	5.00	-	$5.00
Cerity partners	23.64K	-	$23.88K
Truvestments capital	50.00	-	$59.00

Top Buyers

Holder	Shares	% Assets	Change
Sabby management	179.78K	0.38%	179.78K
Newedge advisors	6.80K	-	6.80K
Eversource wealth advisors	4.38K	0.00%	4.38K
Palo alto investors lp	146.02K	0.04%	-
Cornerstone planning group	5.00	-	-

Top Sellers

Holder	Shares	% Assets	Change
Omnia family wealth	62.69K	0.03%	-24.94K
Accent capital management	10.00K	0.01%	-
Truvestments capital	50.00	-	-
Palo alto investors lp	146.02K	0.04%	-
Cerity partners	23.64K	-	-

New Positions

Holder	Shares	% Assets	Change	Value
Sabby management	179.78K	0.38%	179.78K	$210.33K
Newedge advisors	6.80K	-	6.80K	$7.96K
Eversource wealth advisors	4.38K	0.00%	4.38K	$5.12K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	15	50.00%	550,740	80.99%	100	32469.88%	5	-	3	200.00%
Mar 31, 2025	10	-28.57%	304,298	-5.73%	-	30.53%	-	-100.00%	1	-
Dec 31, 2024	14	40.00%	322,783	78.02%	1	244.43%	6	50.00%	1	-
Sep 30, 2024	10	-	181,321	0.63%	-	81.26%	4	-20.00%	-	-
Jun 30, 2024	10	25.00%	180,188	3.12%	-	56.70%	5	400.00%	-	-100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
LUX IM Global Medtech HX	10.26K	0.03%	-
Fidelity Nasdaq Composite Index	1.51K	0.01%	-
RiverNorth Marketplace Lending Corp	1.10K	0.00%	-
RiverNorth Opportunities	509.00	0.00%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 21, 2025	Gaslightwala Abizer	CEO	Buy	$9.40K
Aug 25, 2025	Gaslightwala Abizer	CEO	Buy	$2.70K
Aug 22, 2025	Gaslightwala Abizer	CEO	Buy	$7.44K
Jun 24, 2025	Gaslightwala Abizer	President & CEO	Buy	$6.04K
Jun 23, 2025	Gaslightwala Abizer	President & CEO	Buy	$1.08K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	3	-
2025 Q2	4	-
2025 Q1	-	-
2024 Q4	-	-

AKTX Ownership FAQ

Who Owns Akari Therapeutics?

Akari Therapeutics shareholders are primarily institutional investors at 100.89%, followed by 34.23% insiders and -35.12% retail investors. The average institutional ownership in Akari Therapeutics's industry, Biotech Stocks , is 307.10%, which Akari Therapeutics falls below.

Who owns the most shares of Akari Therapeutics?

Akari Therapeutics’s largest shareholders are Cerity partners (23.64K shares, 150.25%), Sabby management (179.78K shares, 32.93%), and Palo alto investors lp (146.02K shares, 26.75%). Together, they hold 209.93% of Akari Therapeutics’s total shares outstanding.

Does Blackrock own Akari Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Akari Therapeutics.

Who is Akari Therapeutics’s biggest shareholder by percentage of total assets invested?

Sabby management is Akari Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.38% of its assets in 179.78K Akari Therapeutics shares, valued at 210.33K$.

Who is the top mutual fund holder of Akari Therapeutics shares?

LUX IM Global Medtech HX is the top mutual fund holder of Akari Therapeutics shares, with 0.03% of its total shares outstanding invested in 10.26K Akari Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools